Clinical effectiveness of Daikenchuto (DKT: TJ-100) for abdominal pain or distention in perioperative period of pancreaticoduodenectomy

Not Applicable

• Conditions: Patients with pancreatic head tumors undergoing pancreaticoduodenectomy

• Registration Number: JPRN-UMIN000005056
• Lead Sponsor: Wakayama Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-03-01
• Study Completion: 2012-05-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with ischemic heart disease requiring treatment 2)Patients with liver cirrhosis or active hepatitis 3)Patients with interstitial pneumonitis or emphysema 4)Patients with chronic renal failure requiring dialysis 5)Patients with active duplicative malignant disease affecting adverse event 6)Patients who are scheduled to undergo pancreaticoduodenectomy together with other organs 7)Patients with history of intestinal resection 8)Patients who are administered another gastrointestinal prokinetic agents 9)Patients who need another Kampo medicines for medical treatment 10)Others, patients who are unfit for the study as determined by the attending physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified